EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-β signaling in lung fibroblasts

被引:60
|
作者
Li, YJ
Azuma, A
Usuki, J
Abe, S
Matsuda, K
Sunazuka, T
Shimizu, T
Hirata, Y
Inagaki, H
Kawada, T
Takahashi, S
Kudoh, S
Omura, S
机构
[1] Nippon Med Coll, Dept Internal Med 4, Tokyo 113, Japan
[2] Nippon Med Coll, Dept Hyg & Publ Hlth, Tokyo 113, Japan
[3] Univ Tsukuba, Inst Basic Med Sci, Ibaraki, Japan
[4] Kitasato Univ, Kitasato Inst Life Sci, Tokyo, Japan
关键词
D O I
10.1186/1465-9921-7-16
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Fourteen-membered ring macrolides have been effective in reducing chronic airway inflammation and also preventing lung injury and fibrosis in bleomycin-challenged mice via anti-inflammatory effects. EM703 is a new derivative of erythromycin ( EM) without the bactericidal effects. We investigated the anti-inflammatory and antifibrotic effects of EM703 in an experimental model of bleomycin-induced lung injury and subsequent fibrosis in mice. Methods: Seven-week-old male ICR mice were used. All experiments used eight mice/group, unless otherwise noted in the figure legends. Bleomycin was administered intravenously to the mice on day 0. EM703 was orally administered daily to mice. All groups were examined for cell populations in the bronchoalveolar lavage (BAL) fluid and for induction of messenger RNA ( mRNA) of Smad3 and Smad4 in the lung tissues by reverse transcriptase (RT)-polymerase chainreaction (PCR) on day 7. Fibroblastic foci were assessed histologically, and the hydroxyproline content was chemically determined in the lung tissues on day 28. We performed assay of proliferation and soluble collagen production, and examined the induction of mRNA of Smad3 and Smad4 by RTPCR in murine lung fibroblast cell line MLg2908. We also examined Smad3, Smad4 and phosphorylated Smad2/3 (p-Smad2/3) protein assay by western blotting in MLg2908. Results: Bleomycin-induced lung fibrosis, and the infiltration of macrophages and neutrophils into the airspace were inhibited by EM703. The expression of Smad3 and Smad4 mRNA was clearly attenuated by bleomycin, but was recovered by EM703. EM703 also inhibited fibroblast proliferation and the collagen production in lung fibroblasts induced by Transforming growth factor-beta (TGF-beta). The expression of Smad3 and Smad4 mRNA in murine lung fibroblasts disappeared due to TGF-beta, but was recovered by EM703. EM703 inhibited the expression of p-Smad2/3 and Smad4 protein in murine lung fibroblasts induced by TGF-beta. Conclusion: These findings suggest that EM703 improves bleomycin-induced pulmonary fibrosis in mice by actions of anti-inflammation and regulation of TGF-beta signaling in lung fibroblasts.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-β signaling in lung fibroblasts
    Ying Ji Li
    Arata Azuma
    Jiro Usuki
    Shinji Abe
    Kuniko Matsuda
    Toshiaki Sunazuka
    Takako Shimizu
    Yukiyo Hirata
    Hirofumi Inagaki
    Tomoyuki Kawada
    Satoru Takahashi
    Shoji Kudoh
    Satoshi Omura
    [J]. Respiratory Research, 7
  • [2] Sulforaphane attenuates lung fibrosis in bleomycin-induced pulmonary fibrosis via inhibition of TGF-β/Smad signaling
    Kyung, Sun Young
    Kim, You Jin
    Lee, Sang Min
    Kang, Sin Myung
    Lee, Sang Pyo
    Park, Jeong-Woong
    Jeong, Sung Hwan
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [3] Entrectinib ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-ß1 signaling pathway
    Miao, Yang
    Li, Xiaohe
    Yang, Yue
    Zhang, Jianwei
    Chen, Li
    Zhang, Qianyi
    Li, Wenqi
    Liu, Ying
    Zhang, Xianfeng
    Gu, Ruimin
    Yang, Cheng
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 113
  • [4] Baricitinib Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice by Inhibiting TGF-β1 Signaling Pathway
    Gu, Songtao
    Liang, Jingjing
    Zhang, Jianwei
    Liu, Zhichao
    Miao, Yang
    Wei, Yuli
    Li, Shimeng
    Gu, Jinying
    Cui, Yunyao
    Xiao, Ting
    Li, Xiaohe
    Yang, Cheng
    [J]. MOLECULES, 2023, 28 (05):
  • [5] Bergenin attenuates bleomycin-induced pulmonary fibrosis in mice via inhibiting TGF-β1 signaling pathway
    Li, Xiaohe
    Wang, Yanhua
    Liang, Jingjing
    Bi, Zhun
    Ruan, Hao
    Cui, Yunyao
    Ma, Ling
    Wei, Yuli
    Zhou, Bingchen
    Zhang, Liang
    Zhou, Honggang
    Yang, Cheng
    [J]. PHYTOTHERAPY RESEARCH, 2021, 35 (10) : 5808 - 5822
  • [6] Differential Contribution Of Tgf-β Signaling In Mouse Lung Epithelium Versus Mesenchyme To Bleomycin-Induced Pulmonary Fibrosis
    Xu, W.
    Chen, H.
    Zhang, W.
    Xu, B.
    Luo, Y.
    Shi, W.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [7] Selpercatinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF- β 1 signaling pathway
    Li, Shimeng
    Liu, Zhichao
    Jiao, Xiaodan
    Gu, Jinying
    Liu, Zhigang
    Meng, Lingxin
    Li, Wenqi
    Zhang, Tiantian
    Liu, Jing
    Chai, Dan
    Liu, Jiaai
    Yang, Zhongyi
    Liu, Yuming
    Jiao, Ran
    Li, Xiaohe
    Zhou, Honggang
    Zhang, Yanping
    [J]. BIOCHEMICAL PHARMACOLOGY, 2024, 225
  • [8] Zanubrutinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β1 signaling pathway
    Chen, Shanshan
    Wei, Yuli
    Li, Shimeng
    Miao, Yang
    Gu, Jinying
    Cui, Yunyao
    Liu, Zhichao
    Liang, Jingjing
    Wei, Luqing
    Li, Xiaohe
    Zhou, Honggang
    Yang, Cheng
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 113
  • [9] Inhibition of Raf1 ameliorates bleomycin-induced pulmonary fibrosis through attenuation of TGF-β1 signaling
    Li, Shuang
    Liu, Jia
    Tan, Jiangning
    Li, Lian
    Kaltreider, Mary J.
    Zhao, Jing
    Kass, Daniel J.
    Shang, Dong
    Zhao, Yutong
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2018, 315 (02) : L241 - L247
  • [10] Neohesperidin inhibits TGF-β1/Smad3 signaling and alleviates bleomycin-induced pulmonary fibrosis in mice
    Guo, Jiasen
    Fang, Yinshan
    Jiang, Fangxin
    Li, Lian
    Zhou, Honggang
    Xu, Xiaojun
    Ning, Wen
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 864